Company Active LTD

Company profile

Imorphics Limited

Imorphics | Precision. Insight. Innovation.

Imorphics Limited is a UK company with status active founded in 2001 based in South East England.

CRN
04315434
Founded
2001
Age
24

Overview

Legal name
IMORPHICS LIMITED
Region
South East England
Registered address
STRYKER HOUSE
HAMBRIDGE ROAD
NEWBURY
BERKSHIRE
RG14 5AW
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

1 level 1 ultimate controller
1
Company Active LTD
Imorphics Limited
CRN 04315434
2
Direct and ultimate controller
00148492
CRN 00148492

Company events

Reference milestones and recent Companies House filing stream events.

6 events
31 Oct
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

17 Oct
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

25 Oct
2024

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzQ0MDk5NDE0MmFkaXF6a2N4

Published 25 Oct 2024 06:29

01 Nov
2001

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2007
Funded years
2007, 2009, 2014
Age at first award
5 years

Projects

2014 GRD Proof of Concept Lead participant

qRAMRIS

1 Jan 2014 to 31 Jul 2015

Awarded
£99,992
Total cost £169,621

Rheumatoid arthritis (RA) is a painful disease of the joints which affects significant numbers of adults. Powerful drugs are available to treat the disease, however these drugs do have limitations; they are typically expensive and require hospital care to administer. Development of new drugs for RA is hampered by the clinical tools available to assess the...

2009 Collaborative R&D

SHIELD

1 Oct 2009 to 30 Nov 2012

Awarded
£67,929
Total cost £154,383

Acetabular and femoral bone resorption is one of the few remaining clinical challenges to be addressed when considering the long term success of orthopaedic joint replacements, particularly in hip prostheses. Bone resorption around the proximal femoral stem and acetabular cup due to stress shielding contributes to bone loss and reduced bone mineral densit...

2007 Collaborative R&D Lead participant

Automated Analysis of Cartilage Thickness and Tissue Quality from MRI

1 Oct 2007 to 30 Sep 2010

Awarded
£190,480
Total cost £636,364

Awaiting Public Summary

Product types

Collaborative R&D GRD Proof of Concept